首页|前列腺素家族中的PGB2、15-keto-PGE2、8-iso-PGF2α在非酒精性脂肪性肝病中的作用

前列腺素家族中的PGB2、15-keto-PGE2、8-iso-PGF2α在非酒精性脂肪性肝病中的作用

扫码查看
目的 探讨前列腺素家族(prostaglandins,PGs)成员对非酒精性脂肪肝(non-alcoholic fatty liver disease,NAFLD)的影响.方法 以人肝癌细胞系HepG2细胞为研究对象.试验设为对照组(Ctrl)、脂肪变组(FFA)、前列腺素B2(PGB2、10 μg/mL)处理组、15-酮基-前列腺素E2(15-keto-PGE2、10 μg/mL)处理组、8-异前列腺素F2a(8-iso-PGF2a、10 μg/mL)处理组.采用噻唑蓝(MTT)试验检测细胞活性,油红O染色检测脂质沉积,实时荧光定量PCR(qRT-PCR)检测炎性因子基因的表达情况,Western blot检测磷酸化胰岛素受体底物(p-IRS)蛋白的表达水平.另取15只SPF级雄性C57BL/6J小鼠,随机分为基础组(CD组,n=5,10%低脂饲料喂养16周)、高脂组(HFD组,n=5,60%高脂饲料喂养16周,建模NAFLD)、PGB2组(n=5,60%高脂饲料喂养16周后,每天给予尾静脉注射PGB2 20 μg/kg,持续2周).采用小鼠葡萄糖耐量试验(IPGTT)检测小鼠的糖耐量水平,HE染色验证小鼠肝脏脂肪变程度.结果 油红O染色结果显示,PGs对NAFLD的脂质沉积没有显著影响,但PGs能够缓解NAFLD伴随产生的炎症.qRT-PCR结果显示,FFA组IL-1β水平[(2.274±0.550)倍]与对照组相比显著升高(P=0.002 8),而在50 μg/mL PGB2、10μg/mL 15-keto-PGE2 和 10μg/mL 8-iso-PGF2α 的作用下,IL-1β 分别降低至[(0.720±0.036)倍,P=0.003 1、(0.857±0.225)倍,P=0.006 4 和(1.767±0.725)倍,P=0.029 7].Western blot 结果显示,经过 PGs 处理,p-IRS蛋白的表达水平增加.CD组小鼠体重为(28.560±2.028)g,HFD组小鼠体重升高至(49.300±0.667)g,而PGB2组显著降低至(40.840±4.043)g,各组间差异有统计学意义(P=0.001 7);此外,PGB2组葡萄糖耐量结果优于HFD组.HE染色结果显示,与HFD组比较,PGB2组肝脏脂肪变的程度降低.结论 PGs中的PGB2、15-keto-PGE2、8-iso-PGF2α可通过缓解IL-1β介导的炎症,上调p-IRS表达,促进胰岛素信号传导,减轻胰岛素抵抗,缓解NAFLD的发生、发展.
Roles of prostaglandin B2,15-keto-prostaglandin E2,and 8-isoprostane F2α in non-alcoholic fatty liver disease
Objective To investigate the effect of prostaglandin family(PGs)on non-alcoholic fatty liver disease(NAFLD).Methods HepG2 cells,a human hepatocellular carcinoma cell line,were used as the research subject.The experiment was set up as a control group(Ctrl),fatty change group(FFA),prostaglandin B2(PGB2,10 μg/mL)treatment group,15-keto-prostaglandin E2(15-keto-PGE2,10 μg/mL)treatment group,and 8-iso-prostaglandin F2a(8-iso-PGF2α,10 μg/mL)treatment group.Cell activity was determined by the thiazolyl blue(MTT)assay and lipid deposition was detected by the oil red O staining.The expression levels of inflammatory factors and phosphorylated insulin receptor substrates(p-IRS)were determined by real-time fluorescence quantitative PCR(qRT-PCR)and Western blot,respectively.In addition,15 SPF-grade male C57BL/6J mice were randomly divided into a basic group(CD group,n=5,fed with 10%low-fat forage for 16 weeks),high-fat group(HFD group,n=5,fed with 60%high-fat forage for 16 weeks to model NAFLD),and PGB2 group(n=5,given 20 μg/kg PGB2 daily by tail vein injection for 2 weeks after 16 weeks of 60%high-fat diet feeding).The glucose tolerance level of the mice was detected by the intraperitoneal glucose tolerance test(IPGTT)and the degree of hepatic steatosis was determined by HE staining.Results Oil red O staining showed that PGs had no sig-nificant effect on the lipid deposition of NAFLD,but PGs were able to alleviate the inflammation associated with NAFLD.qRT-PCR re-sults showed that compared with the Ctrl group,the levels of IL-1β in the FFA group increased by 2.274±0.550 times(P=0.002 8),while under the action of 50 μg/mL PGB2,10 μg/mL 15-keto-PGE2 and 10 μg/mL 8-iso-PGF2α,the levels of IL-1β decreased to 0.720±0.036 times(P=0.003 1),0.857±0.225 times(P=0.006 4),and 1.767±0.725 times(P=0.029 7),respectively.Western blot results showed that after PGs treatment,the expression level of p-IRS protein was increased.The body weights of mice in the CD group,HFD group and PGB2 group were(28.560±2.028)g,(49.300±0.667)g,and(40.840±4.043)g,respectively,with statisti-cally significant differences between the groups(P=0.001 7).Moreover,the glucose tolerance results in the PGB2 group were better than those in the HFD group.HE staining results showed compared with the HFD group,the degree of hepatic steatosis in the PGB2 group was reduced.Conclusion PGB2,15-keto-PGE2,and 8-iso-PGF2α in the prostaglandin family can alleviate the occurrence and development of NAFLD by alleviating IL-1β-mediated inflammation,upregulating the expression of p-IRS,promoting the transmission of insulin signaling,and attenuating insulin resistance.

prostaglandinnon-alcoholic fatty liver diseaseinflammationinsulin resistancephospho-insulin receptor substrates

高毅男、王培君、叶棣文、郭泽郡、逯素梅

展开 >

山东第一医科大学第一附属医院/山东省千佛山医院检验科,山东省医药卫生临床检验诊断学重点试验室,济南 250014

济南市中心医院检验科,济南 250013

潍坊医学院医学检验学院,山东潍坊 261053

前列腺素 非酒精性脂肪肝 炎症 胰岛素抵抗 磷酸化胰岛素受体底物

山东第一医科大学青年科学基金培育资助计划山东省自然科学基金资助项目山东省自然科学基金资助项目

202201-083ZR2023MH031ZR2021MH187

2024

临床检验杂志
江苏省医学会

临床检验杂志

CSTPCD
影响因子:0.746
ISSN:1001-764X
年,卷(期):2024.42(7)
  • 21